Jeff Hunnicutt: Highlands Oncology Group announces a partnership with Agamon Health
Jeff Hunnicutt, Chief Executive Officer at Highlands Oncology Group, reshared a post by Michal Meiri, Co-Founder & CEO at Agamon Healtn, on LinkedIn, adding:
“Highlands Oncology Group is excited to announce a partnership with Agamon Health as we develop AI-assisted technology aimed at augmenting our referral and intake process.
The team at Agamon has been incredible and we can’t wait to see the end result in action!”
Quoting Michal Meiri‘s post:
“We’re growing fast at Agamon Health and thrilled to announce new partnerships with Highlands Oncology Group, Oregon Specialty Group and Oklahoma Cancer Specialists and Research Institute.
What excites me most is the opportunity to work with forward-thinking executives like Jeff Hunnicutt, Mel Davies and Maxwell Thorsbakken thought leaders in leveraging AI to transform cancer care and improve outcomes for patients.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023